Variable | 'At-risk' | 'Control' | OR (95%CI) | p-value |
---|---|---|---|---|
Children with a malaria episode in the past two weeks | Â | Â | Â | Â |
('at-risk', n = 1003; 'control', n = 953) | 21.8% | 15.8% | 1.49 (0.46-4.76) | 0.483 |
Children receiving treatment | Â | Â | Â | Â |
('at-risk', n = 159; 'control', n = 208) | 75.5% | 84.6% | 0.56 (0.29-1.08) | 0.079 |
The first action taken | Â | Â | Â | Â |
('at-risk', n = 120; 'control', n = 176) | Â | Â | Â | Â |
Took the child to health services | 60.0% | 68.8% | Â | 0.265 |
Treat with anti-malarials at home | 35.8% | 23.3% | Â | Â |
Treat with herbs at home | 2.5% | 6.8% | Â | Â |
Other | 1.7% | 1.1% | Â | Â |
Use of anti-malarial remedies | Â | Â | Â | Â |
('at-risk', n = 120; 'control', n = 179) | 81.7% | 79.3% | 1.16 (0.29-4.65) | 0.820 |
Type of anti-malarial(s) given | Â | Â | Â | Â |
('at-risk', n = 98; 'control', n = 142) | Â | Â | Â | Â |
Coartem® (artemether-lumefantrine (AL)) | 56.1% | 74.6% |  | 0.392 |
Chloroquine (CQ) | 34.7% | 21.8% | Â | Â |
Fansidar® (sulfadoxine-pyrimethamine (SP)) | 9.2% | 2.1% |  |  |
Quinine (QN) | 0.0% | 1.4% | Â | Â |
The child finished the dose | Â | Â | Â | Â |
('at-risk', n = 142; 'control', n = 98)) | Â | Â | Â | Â |
Yes | 95.9% | 95.1% | 1.22 (0.13-11.73) | 0.853 |
Reasons for absence of treatment | Â | Â | Â | Â |
('at-risk', n = 39; 'control', n = 32) | Â | Â | Â | Â |
Lack of money | 76.9% | 53.1% | Â | 0.114 |
Health facility very far | 5.2% | 28.1% | Â | Â |
Child not seriously ill | 15.4% | 18.8% | Â | Â |
Others | 2.6% | 0.0% | Â | Â |